Review



castar hood for cpap therapy, infant type  (STARmed Co Ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    STARmed Co Ltd castar hood for cpap therapy, infant type
    Castar Hood For Cpap Therapy, Infant Type, supplied by STARmed Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/castar hood for cpap therapy, infant type/product/STARmed Co Ltd
    Average 90 stars, based on 1 article reviews
    castar hood for cpap therapy, infant type - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    castar hood for cpap therapy, infant type  (STARmed Co Ltd)
    90
    STARmed Co Ltd castar hood for cpap therapy, infant type
    Castar Hood For Cpap Therapy, Infant Type, supplied by STARmed Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/castar hood for cpap therapy, infant type/product/STARmed Co Ltd
    Average 90 stars, based on 1 article reviews
    castar hood for cpap therapy, infant type - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    helmet cpap castar hood for cpap therapy  (Intersurgical inc)
    90
    Intersurgical inc helmet cpap castar hood for cpap therapy
    Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the <t>Helmet</t> <t>CPAP</t> group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure
    Helmet Cpap Castar Hood For Cpap Therapy, supplied by Intersurgical inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/helmet cpap castar hood for cpap therapy/product/Intersurgical inc
    Average 90 stars, based on 1 article reviews
    helmet cpap castar hood for cpap therapy - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    helmet cpap (castar hood cpap therapy  (Intersurgical inc)
    90
    Intersurgical inc helmet cpap (castar hood cpap therapy
    Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the <t>Helmet</t> <t>CPAP</t> group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure
    Helmet Cpap (Castar Hood Cpap Therapy, supplied by Intersurgical inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/helmet cpap (castar hood cpap therapy/product/Intersurgical inc
    Average 90 stars, based on 1 article reviews
    helmet cpap (castar hood cpap therapy - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    cpap hood  (STARmed Co Ltd)
    90
    STARmed Co Ltd cpap hood
    Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the <t>Helmet</t> <t>CPAP</t> group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure
    Cpap Hood, supplied by STARmed Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cpap hood/product/STARmed Co Ltd
    Average 90 stars, based on 1 article reviews
    cpap hood - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    helmet castar cpap hood large  (STARmed Co Ltd)
    90
    STARmed Co Ltd helmet castar cpap hood large
    Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the <t>Helmet</t> <t>CPAP</t> group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure
    Helmet Castar Cpap Hood Large, supplied by STARmed Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/helmet castar cpap hood large/product/STARmed Co Ltd
    Average 90 stars, based on 1 article reviews
    helmet castar cpap hood large - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    hood cpap  (STARmed Co Ltd)
    90
    STARmed Co Ltd hood cpap
    Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the <t>Helmet</t> <t>CPAP</t> group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure
    Hood Cpap, supplied by STARmed Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hood cpap/product/STARmed Co Ltd
    Average 90 stars, based on 1 article reviews
    hood cpap - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the Helmet CPAP group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure

    Journal: Trials

    Article Title: Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET)

    doi: 10.1186/s13063-020-04863-5

    Figure Lengend Snippet: Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the Helmet CPAP group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure

    Article Snippet: Helmet CPAP (CaStar hood for CPAP therapy by Starmed/Intersurgical) driven by high-flow blender (Bio-Med Devices).

    Techniques: Control, Concentration Assay

    Journal: Trials

    Article Title: Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET)

    doi: 10.1186/s13063-020-04863-5

    Figure Lengend Snippet:

    Article Snippet: Helmet CPAP (CaStar hood for CPAP therapy by Starmed/Intersurgical) driven by high-flow blender (Bio-Med Devices).

    Techniques: Infection